SCHEMBL19414398

SCHEMBL19414398

CCOc1cccc(-c2n[nH]c3ncnc(N)c23)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.54
FGFR2 P21802 2/20 0.50
FGFR3 P22607 2/20 0.50
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
PIK3CD O00329 5/20 0.47
PIK3CA P42336 5/20 0.47
PIK3CB P42338 5/20 0.47
PIK3CG P48736 5/20 0.47
PRKDC P78527 5/20 0.47
TTK P33981 4/20 0.47
MAPK8 P45983 3/20 0.47
SRC P12931 6/20 0.46
ABL1 P00519 5/20 0.46
HCK P08631 3/20 0.46
EGFR P00533 3/20 0.46
KDR P35968 2/20 0.46
MTOR P42345 2/20 0.46
EPHB4 P54760 2/20 0.46
NOTUM Q6P988 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20793606 0.90 KDM4E (0.47) MAP4K4FGFR2FGFR3MAPTPIK3CD
SCHEMBL145785 0.87 SRC (0.56) MAP4K4GAAPIK3CDPIK3CAPIK3CB
SCHEMBL20093454 0.86 SRC (0.61) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL21048477 0.84 PIK3CD (0.67) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL19414293 0.84 ALDH1A1 (0.50) MAPTPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL21364711 0.84 MAP4K4 (0.52) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL15276905 0.84 PIK3CD (0.45) MAP4K4GAAPIK3CDPIK3CAPIK3CB
SCHEMBL30387716 0.84 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30387451 0.82 PIK3CD (0.69) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL21467047 0.82 FGFR1 (0.45) FGFR2FGFR3PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858907-B2 Kinase modulators RHIZEN PHARMACEUTICALS AG (CH) 2024-01-02 US disclosed
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 US disclosed
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 US disclosed
US-10220035-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-03-05 US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 US disclosed
US-9775841-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2017-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKAR2B MAP4K4 119/4885FGFR2 2905/4885FGFR3 2701/4885
US-10220035-B2 Compounds as modulators of protein kinases PRKCA, PRKCH, PRKCE MAP4K4 144/4885FGFR2 2730/4885FGFR3 2716/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB MAP4K4 129/4885FGFR2 2741/4885FGFR3 2881/4885
US-10322130-B2 Substituted chromenones as modulators of protein kinases MAP3K1, CSNK1A1, MAP3K2 MAP4K4 87/4885FGFR2 2173/4885FGFR3 2592/4885
US-11858907-B2 Kinase modulators RPS6KA1, RPS6KA2, PRKAR2A MAP4K4 145/4885FGFR2 2332/4885FGFR3 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.